🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,196 results for “GE” Clear

  1. dupilumab

    Regeneron UK Limited

    Bullous Pemphigoid

    phase 3 small molecule completed

    1 trial

  2. dydrogesterone

    Hospital Authority, Hong Kong

    Preterm Delivery

    phase 3 small molecule completed

    1 trial

  3. efgartigimod PH20 SC

    argenx

    Bullous Pemphigoid

    phase 3 mab completed

    1 trial

  4. esophagectomy

    The First People's Hospital of Lianyungang

    Esophageal Cancer

    phase 3 other active

    1 trial

  5. evinacumab

    Regeneron UK Limited

    Homozygous Familial Hypercholesterolemia

    phase 3 small molecule completed

    3 trials

  6. evorpacept, Herceptin 150 mg powder for concentrate for solution for infusion, Cyramza 10 mg/ml concentrate for solution for infusion, Paclitaxel 6 mg/mL concentrate for solution for infusion, Normal Saline (Sodium Chloride)

    Wuhan Createrna Science and Technology Co., Ltd

    Patients with HER2-overexpressing advanced or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma that has progressed on or after a prior HER2-directed agent and fluoropyrimidine- or platinum-containing chemotherapy (2nd-line or 3rd-line)

    phase 3 small molecule active

    1 trial

  7. favezelimab/pembrolizumab

    Merck KGaA, Darmstadt, Germany

    Colorectal Cancer

    phase 3 mab completed

    1 trial

  8. fianlimab

    Regeneron UK Limited

    Non-small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  9. fianlimab

    Regeneron UK Limited

    Advanced Non-Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  10. fixed dose combination of telmisartan+amlodipine

    Boehringer Ingelheim

    Hypertension

    phase 3 small molecule completed

    1 trial

  11. ganciclovir

    Ultragenyx UK Limited

    Cytomegalovirus Infections

    phase 3 small molecule completed

    1 trial

  12. garetosmab

    Regeneron UK Limited

    Fibrodysplasia Ossificans Progressiva (FOP)

    phase 3 small molecule active

    1 trial

  13. garetosmab

    Regeneron UK Limited

    Fibrodyplasia Ossificans Progressiva (FOP)

    phase 3 small molecule terminated

    1 trial

  14. gemcitabine

    NORTHWEST BIOTHERAPEUTICS INC

    Non-Small Cell Lung Cancer

    phase 3 small molecule terminated

    1 trial

  15. gemcitabine and cisplatin (Induction chemotherapy)

    Sun Yat-sen University

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  16. gemcitabine and cisplatin (Induction chemotherapy)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  17. gemcitabine and cisplatin; docetaxel, cisplatin and fluorouracil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  18. gemcitabine,nimotuzumab, toripalimab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  19. gene expression analysis

    United Therapeutics Europe Ltd

    Kidney Cancer

    phase 3 gene therapy active

    1 trial

  20. gentamicin

    BRIGHT MINDS BIOSCIENCES INC.

    Plague

    phase 3 small molecule completed

    1 trial

  21. giroctocogene fitelparvovec

    Pfizer Australia Pty Ltd

    hemophilia A

    phase 3 small molecule active

    1 trial

  22. giroctocogene fitelparvovec, fidanacogene elaparvovec

    Pfizer Australia Pty Ltd

    hemophilia A, severe to moderately severe hemophilia B (FIX:C ≤ 2%)

    phase 3 small molecule active

    1 trial

  23. guanfacine

    Ultragenyx UK Limited

    Tourette Syndrome

    phase 3 small molecule completed

    1 trial

  24. iloprost

    Ultragenyx UK Limited

    Systemic Sclerosis

    phase 3 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources